Cargando…
New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
Autores principales: | Zavala-Miranda, María Fernanda, González-Ibarra, Samantha G., Pérez-Arias, Abril A., Uribe-Uribe, Norma O., Mejia-Vilet, Juan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455236/ https://www.ncbi.nlm.nih.gov/pubmed/34560139 http://dx.doi.org/10.1016/j.kint.2021.09.009 |
Ejemplares similares
-
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
por: Mejía-Vilet, Juan M., et al.
Publicado: (2021) -
AZD-1222: New-onset systemic lupus erythematosus with class V lupus nephritis: case report
Publicado: (2022) -
Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022) -
Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
por: Hajji, Meriam, et al.
Publicado: (2023)